SRC and cancer: Beyond inhibiting SRCs to treat cancer, a SRC small molecule stimulator (MCB-613) was identified that led to cancer cell death through over-activation of SRC transcriptional activity, leading to endoplasmic reticulum stress and high levels of reactive oxygen species (140).